APH Stock Overview
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for APH from our risk checks.
Alliance Pharma plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.37 |
| 52 Week High | UK£0.73 |
| 52 Week Low | UK£0.34 |
| Beta | 0.58 |
| 1 Month Change | -0.54% |
| 3 Month Change | 0% |
| 1 Year Change | -41.29% |
| 3 Year Change | -61.52% |
| 5 Year Change | -52.15% |
| Change since IPO | 83.75% |
Recent News & Updates
Not Many Are Piling Into Alliance Pharma plc (LON:APH) Just Yet
Feb 23
Estimating The Intrinsic Value Of Alliance Pharma plc (LON:APH)
Nov 21Recent updates
Not Many Are Piling Into Alliance Pharma plc (LON:APH) Just Yet
Feb 23Estimating The Intrinsic Value Of Alliance Pharma plc (LON:APH)
Nov 21We Think Alliance Pharma (LON:APH) Is Taking Some Risk With Its Debt
May 26Alliance Pharma plc Just Missed Earnings - But Analysts Have Updated Their Models
Mar 24We Think Alliance Pharma (LON:APH) Can Stay On Top Of Its Debt
Sep 30An Intrinsic Calculation For Alliance Pharma plc (LON:APH) Suggests It's 41% Undervalued
May 28Alliance Pharma (LON:APH) Has A Pretty Healthy Balance Sheet
Mar 30Did Alliance Pharma's (LON:APH) Share Price Deserve to Gain 81%?
Dec 24Do Fundamentals Have Any Role To Play In Driving Alliance Pharma plc's (LON:APH) Stock Up Recently?
Nov 19
Shareholder Returns
| APH | GB Pharmaceuticals | GB Market | |
|---|---|---|---|
| 7D | -3.0% | -1.2% | -0.7% |
| 1Y | -41.3% | -5.0% | -1.8% |
Return vs Industry: APH underperformed the UK Pharmaceuticals industry which returned -5.3% over the past year.
Return vs Market: APH underperformed the UK Market which returned -2.4% over the past year.
Price Volatility
| APH volatility | |
|---|---|
| APH Average Weekly Movement | 5.3% |
| Pharmaceuticals Industry Average Movement | 8.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: APH has not had significant price volatility in the past 3 months.
Volatility Over Time: APH's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 285 | Andrew Franklin | www.alliancepharmaceuticals.com |
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.
Alliance Pharma plc Fundamentals Summary
| APH fundamental statistics | |
|---|---|
| Market cap | UK£198.60m |
| Earnings (TTM) | -UK£7.06m |
| Revenue (TTM) | UK£170.05m |
1.2x
P/S Ratio-28.1x
P/E RatioIs APH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| APH income statement (TTM) | |
|---|---|
| Revenue | UK£170.05m |
| Cost of Revenue | UK£72.14m |
| Gross Profit | UK£97.91m |
| Other Expenses | UK£104.97m |
| Earnings | -UK£7.06m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Apr 23, 2024
| Earnings per share (EPS) | -0.013 |
| Gross Margin | 57.58% |
| Net Profit Margin | -4.15% |
| Debt/Equity Ratio | 43.6% |
How did APH perform over the long term?
See historical performance and comparison